# A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM

> **NCT00308451** · NA · COMPLETED · sponsor: **Nutrition 21, Inc.** · enrollment: 40 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)

## Key facts

- **NCT ID:** NCT00308451
- **Lead sponsor:** Nutrition 21, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308451, "A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00308451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*